Format

Send to

Choose Destination
See comment in PubMed Commons below
Lancet Respir Med. 2013 Jul;1(5):e23. doi: 10.1016/S2213-2600(13)70104-8. Epub 2013 Jul 8.

QVA149 versus glycopyrronium for COPD - authors' reply.

Author information

1
Centre for Respiratory Medicine, University College London, Royal Free Campus, London NW3 2PF, UK. Electronic address: w.wedzicha@ucl.ac.uk.
2
Respiratory Division, University Hospital, University of Leuven, Leuven, Belgium.
3
Paracelsus Medical University Nuremberg, Nuremberg, Germany; Klinikum Nuernberg, Department of Respiratory Medicine, Allergology, Sleep Medicine, Nuernberg, Germany.
4
University of Minnesota, Minneapolis VA Medical Center, Minneapolis, MN, USA.
5
Umea University, Department of Public Health and Clinical Medicine, Umea, Sweden.
6
Novartis Pharmaceuticals, East Hanover, NJ, USA.
PMID:
24429211
DOI:
10.1016/S2213-2600(13)70104-8
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center